RxNorm 1736470 NDC Crossover
eptifibatide 20 MG in 10 ML Injection
Related NDC Codes to RxNorm Concept 1736470
The following NDC codes crossover to the RxNorm Concept 1736470. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 14335-070 | Eptifibatide | Hainan Poly Pharm. Co., Ltd. | INACTIVATED | ||||
| 14335-071 | Eptifibatide | Hainan Poly Pharm. Co., Ltd. | INACTIVATED | ||||
| 25021-408 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Sagent Pharmaceuticals | ACTIVE | |
| 25021-409 | Eptifibatide | Sagent Pharmaceuticals | |||||
| 52958-040 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | ACTIVE | |
| 52958-402 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | ACTIVE | |
| 55150-218 | Eptifibatide | Eptifibatide | Injection | Intravenous | Eugia Us Llc | ACTIVE | |
| 55150-219 | Eptifibatide | Eptifibatide | Injection | Intravenous | Eugia Us Llc | ACTIVE | |
| 55150-220 | Eptifibatide | Eptifibatide | Injection | Intravenous | Eugia Us Llc | ACTIVE | |
| 67457-629 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 67457-630 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 67457-631 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 70121-1002 | Eptifibatide | Eptifibatide | Injection | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE | |
| 70121-1003 | Eptifibatide | Eptifibatide | Injection | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE | |
| 70436-026 | Eptifibatide | Eptifibatide | Injection | Intravenous | Slate Run Pharmaceuticals, Llc | ACTIVE | |
| 70436-027 | Eptifibatide | Eptifibatide | Injection | Intravenous | Slate Run Pharmaceuticals, Llc | ACTIVE | |
| 70436-162 | Eptifibatide | Eptifibatide | Injection | Intravenous | Slate Run Pharmaceuticals, Llc | ACTIVE | |
| 70436-163 | Eptifibatide | Eptifibatide | Injection | Intravenous | Slate Run Pharmaceuticals, Llc | ACTIVE | |
| 71288-412 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
| 71288-413 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
| 72078-025 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 72078-026 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 72078-027 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 83634-300 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Avenacy Inc. | ACTIVE | |
| 83634-301 | Eptifibatide | Eptifibatide | Injection, Solution | Intravenous | Avenacy Inc. | ACTIVE |
